←
Jeremy Docken73 posts
Jeremy Docken avatar

Jeremy Docken

@JeremyGDocken

Discussing issues facing the healthcare system and joys and challenges of running a healthcare technology company. Plus other things that I find interesting.

◷ Joined March 2020▧ 3 Photos and videos
Robert Popovian 🇺🇸 🇦🇲 avatar
⟳ Jeremy Docken retweeted
Robert Popovian 🇺🇸 🇦🇲@PopovianPharmD·15 Nov 2022

As I have stated previously, @GoodRx is a PBM scam, another form of spread pricing. Patients benefit from paying cash for some of the most often prescribed generic medications. There are far better options for patients to pay cash e.g., Costco drugchannels.net/2022/11/beh…

Antonio Ciaccia avatar
⟳ Jeremy Docken retweeted
Antonio Ciaccia@A_Ciaccia·23 Aug 2022

I bet there are some grumpy faces up in Dublin, Ohio this evening after reading this one. Ouch.

Warren Buffett once said that the best business to be in is a royalty on the growth of others. Cardinal Health has seen declining profitability even though that's basically what a drug distributor does-- take a royalty on the growth of the pharma industry. wsj.com/articles/failing-in-…

Robert Popovian 🇺🇸 🇦🇲 avatar
⟳ Jeremy Docken retweeted
Robert Popovian 🇺🇸 🇦🇲@PopovianPharmD·22 Jun 2022

Insurers and PBMs are Undermining Employee Health Benefits Employers have the power and they need to ensure that their employee drug benefits are protected from PBM/insurer profit-seeking practices @GHLForg @ppi @PioneerBoston healthcarebusinesstoday.com/… via @HCBizToday

Drug Channels avatar
⟳ Jeremy Docken retweeted
Drug Channels@DrugChannels·9 Jun 2022

A timely reminder that #insulin #drug prices are not what they seem: "Understanding Insulin Prices" Do politicians understand that out-of-pocket costs, not list prices, are patients’ biggest challenge? @PioneerBoston @InsideSourcesDC #GrossToNetBubble drugch.nl/3xb8rPW

Robert Popovian 🇺🇸 🇦🇲 avatar
⟳ Jeremy Docken retweeted
Robert Popovian 🇺🇸 🇦🇲@PopovianPharmD·12 Jan 2021

Questions: What happens to patients whose medication is no longer covered by the PBM? Do insurers who now supposedly own these PBMs care about the total cost of care due to poor outcomes? Answers: WHO CARES & NO since rebate contracting driving this behavior is far more lucrative

Post attachment
Jeremy Docken avatar
Jeremy Docken@JeremyGDocken·4 Jan 2021

Great paper showing why HHS's "world without rebates" Part D rule is good policy for directing drug discounts where they matter-to reduce patient OOP spend.

My paper published in Health Science Journal analyzing how rebate contracting for pharmaceuticals leads to higher out of pocket costs for patients, higher healthcare spending and worsening patient compliance #Pharmaceutical #healthcare #patients hsj.gr/medicine/reforming-re…

Jeremy Docken avatar
Jeremy Docken@JeremyGDocken·21 Oct 2020

Information asymmetries in healthcare have to be overcome to make our healthcare system work as voters and patients need it to work. The good news is, platforms are perfectly suited to solve information asymmetry issues by connecting stakeholders. forbes.com/sites/sethjoseph/…